Genematrix (XKRX:109820) Marketable Securities : ₩12,169 Mil (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Genematrix Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Genematrix's Marketable Securities for the quarter that ended in Dec. 2024 was ₩12,169 Mil.

Genematrix's annual Marketable Securities increased from Dec. 2022 (₩11,500 Mil) to Dec. 2023 (₩11,829 Mil) and increased from Dec. 2023 (₩11,829 Mil) to Dec. 2024 (₩12,169 Mil).

Genematrix Marketable Securities Historical Data

The historical data trend for Genematrix's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genematrix Marketable Securities Chart

Genematrix Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

4,217.06

4,700.00

11,500.00

11,829.48

12,168.78

Genematrix Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Marketable Securities	Get a 7-Day Free Trial															11,829.48	11,883.78	11,968.78	12,168.27	12,168.78

Genematrix Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Genematrix (XKRX:109820) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Genematrix Marketable Securities Related Terms

Thank you for viewing the detailed overview of Genematrix's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Genematrix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genematrix Inc (XKRX:109820) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

700, Daewangpangyo-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 463-400

Website

http://www.genematrix.net

Genematrix Inc is a biotech company engaged in the development of the platform and molecular diagnostics products. Its products include NeoPlexTM STI-7 Detection kit, OmniPlex-HPV, PapilloTyper, HepB Typer-Adefovir, and HepB Typer-Precore among others.

Genematrix Headlines

No Headlines